NovoCure Limited - Ordinary Shares (NVCR)
NASDAQ · Healthcare
$15.94+0.13%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- $1.9B
- P/E ratio
- —
- EPS
- —
- Volume
- 904,722
- 52-week high
- —
- 52-week low
- —
- Open
- $16.00
- Day high
- $16.19
- Day low
- $15.80
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $655.35M | -$136.23M | -$1.22 |
| 2024 | $605.22M | -$168.63M | -$1.56 |
| 2023 | $509.34M | -$207.04M | -$1.95 |
| 2022 | $537.84M | -$92.53M | -$0.88 |
| 2021 | $535.03M | -$58.35M | -$0.56 |
About NovoCure Limited - Ordinary Shares
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include Optune Gio, Optune Lua, and Optune Pax. The company also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
- CEO
- Frank Leonard
- Employees
- 1,605
- Country
- CH
- IPO date
- Oct 2, 2015
Similar stocks
Other Healthcare companies
Frequently asked questions
- What is NovoCure Limited - Ordinary Shares's stock price today?
- NVCR is trading at $15.94 as of Jul 20, 2026.
- What is NovoCure Limited - Ordinary Shares's market cap?
- NovoCure Limited - Ordinary Shares (NVCR) has a market capitalization of $1.9B.
- Does NovoCure Limited - Ordinary Shares pay a dividend?
- NovoCure Limited - Ordinary Shares did not pay a dividend in its most recent reported fiscal year.
- What sector is NovoCure Limited - Ordinary Shares in?
- NovoCure Limited - Ordinary Shares operates in the Healthcare sector.